Abstract
Osteoporosis is a leading cause of morbidity in patients with inflammatory bowel disease (IBD). Bone loss is an early systemic process and occurs even before clinical disease manifests. Bone disease is attributed to vitamin D deficiency, steroid use, and/or systemic inflammation. In this review, we discuss the molecular pathways of bone loss mediated by inflammatory cytokines and other mediators. Further research will hopefully clarify the mechanisms of inflammation-induced bone loss in IBD and guide effective treatment modalities.
Original language | English (US) |
---|---|
Pages (from-to) | 251-257 |
Number of pages | 7 |
Journal | Current Osteoporosis Reports |
Volume | 9 |
Issue number | 4 |
DOIs | |
State | Published - Dec 2011 |
Externally published | Yes |
Keywords
- Bone
- Bone loss
- Cytokines
- Inflammation
- Inflammatory bowel disease
- Osteoblast
- Osteoclast
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism